2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$7.40+$0.22 (+3.14%)
Price as of Oct 22, 2026 7:30 PM EDT- $473.3MMarket Cap
- -41.18%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$7.40+$0.22 (+3.14%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.17 | ||
Change | -$0.23 (-3.11%) | ||
Open | $7.42 | ||
High | $7.47 | ||
Low | $7.15 | ||
Previous Close | $7.40 | ||
Volume | 945,330 | ||
30-Day Average Volume | 1,425,906 | ||
1-Week Change | 4.22% | ||
1-Month Change | -9.01% | ||
1-Year Change | -41.18% | ||
3-Year Change | -55.63% | ||
5-Year Change | -79.53% | ||
Fundamentals | |||
Shares Outstanding | 66.0M | ||
Total Assets | $386.6M | ||
Market Cap | $473.3M | ||
Enterprise Value | $436.8M | ||
Period: QTR TTM FY | |||
Revenue | $103.8M | ||
Net Income | $22.7M | ||
Free Cash Flow | -$63.0M | ||
EBIT | $22.7M | ||
EBITDA | $26.5M | ||
Net Working Capital | $153.5M | ||
EPS | $0.43 | ||
Enterprise Value/EBITDA | 17 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 7 | ||
P/E | 17 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue